// App-Quantinova.ai

PO1450 : Relationships Between CKD Duration, Serum Potassium Level, and Adverse Outcomes

Researchers

Presenter

  • Tafesse Eskinder

Principal Investigators

  • James Glen

  • Hurst MichaelA

  • Hoskin Louise

  • Badora Karolina

  • Sugrue Daniel

  • McEwan Philip

Medical Centers

  • Global Health Economics, AstraZeneca, Gaithersburg, MD, United States

  • Global Medical Affairs, AstraZeneca, Cambridge, United Kingdom

  • (HEOR) Ltd, Health Economics and Outcomes Research, Cardiff, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Congestive heart failure

  • Arrhythmia

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved